Fig 1: Effects of siRNA-mediated knockdown of CDK9, SPT5, and NELF-E on HSV-1 gene expression and DNA replication. siRNAs for CDK9 (a), SPT5 (b), and NELF-E (c) were used in knockdown experiments in 1BR.3.N cells. After the knockdown, the cells were infected with HSV-1 and harvested 19 h.p.i. for either immunoblot or qPCR. As comparison, cells with no knockdown were infected with HSV-1 in the absence and presence of DRB in parallel to the knockdown experiments. Each experiment was subjected to three independent repeats, and the mean value is displayed in the diagrams. Error bars indicate standard deviation.
Fig 2: Model of how multivalent, allosteric interactions between an eRNA and the paused elongation complex (PEC) stimulate Pol II pause release.Following the transcription of a nearby, activated enhancer, an eRNA molecule contacts the paused elongation complex (consisting of Pol II, DSIF, and NELF) at the target gene promoter. The eRNA interacts with NELF at multiple sites (positive patches on NELF-AC, the NELF-A and -E tentacles, and the NELF-E RRM domain). These multivalent, allosteric interactions collectively trigger NELF detachment from the PEC. The resulting elongation complex (consisting of Pol II and DSIF) then resumes transcription elongation. The length of the eRNA (>200) and unpaired guanosines within an eRNA are essential for its ability to detach NELF from the PEC.
Fig 3: NELF occupancy is correlated with Pol II pause release and causal to transcription induction in vivo.a Example track that shows an activity-induced gene, Junb (Blue shaded at its promoter) and its nearby enhancer (Yellow shaded area). Transcript units determined by de novo transcript calls are shown on the top together with tracks for ChIP- (H3K27ac, NELF-E, and Pan Pol II), GRO-, and mRNA-seq. b, c The average GRO-seq profiles of four different gene groups based on the levels of NELF binding (NELF-high [216], -mid [133], -low [199], or -unbound [75]) (b) and two different enhancer groups (NELF-bound [144] or -unbound [108] (c). The profiles are shown for ±2 kb regions centered on the TSSs or the enhancer centers upon 0, 10, 30, and 60 min KCl stimulation. Orange lines denote the sense strand at promoters and the forward strand at enhancers. Green lines denote the anti-sense strand at promoters and the reverse strand at enhancers. d, e Pausing index (PI) profiles of four different gene groups based on their levels of NELF binding with all genes (d) and KCl-up/NELF-bound (144) or -unbound (108) enhancers (e). Each gene group is analyzed at four time points (0, 10, 30, and 60 min KCl). The PI is defined in Supplementary Fig. 11d. Statistical significance between cumulative probability graphs was determined by the Kolmogorov–Smirnov test. Source data for (b–e) are provided in a Source Data file.
Fig 4: eRNAs form an extensive interaction network with the N-terminal region of NELF-E and the tentacles of NELF-A and NELF-E.a The bar plot visualizes the total number of protein–RNA crosslinks (total count of nseen) to each NELF subunit for four (out of eight) eRNA crosslinking experiments to the isolated NELF complex and for two (out of two) experiments with the entire PEC (Supplementary Fig. 4a, experiments marked in red; Supplementary Data 4–7). Below is a 10% SDS-PAGE of two crosslinking experiments of 4SU-labeled Nr4a1-(a) eRNAs 1–100, before (-) and after (+) 365 nm-induced crosslinking to the NELF complex is shown. 40% and 80%-4SU denote the concentration of 4-thiouridine vs. uridine during in vitro transcription (Supplementary Fig. 4a, Methods). Upon crosslinking predominantly NELF-E and NELF-A disappears while high-molecular bands corresponding to crosslinked protein–RNA products appear (marked by red asterisks). b Total number of nucleotide-crosslinks at each amino acid (aa) position plotted along the NELF-E sequence (1–380 aa). Data were shown for the same samples as in (a). The crosslinking results for all eight experiments are shown in Supplementary Fig. 5. Clusters of crosslinks or single crosslinking positions that are present throughout all samples are highlighted. Representative amino acid residues are indicated above the highlighted boxes. The domain architecture of NELF-E is schematically displayed on top. c Distribution of all crosslinks plotted in (b) between the N-terminal portion of NELF-E and the NELF-E tentacle. d Nucleotide-crosslinks to NELF-A plotted as in (b). e Distribution of all crosslinks plotted in (d) between the NELF-AC lobe and the NELF-A tentacle. f Nucleotide-crosslinks to the NELF-AC lobe mapped onto the PEC (PDB code 6GML) displayed in the left panel. Crosslinked residues in the vicinity of the positively charged patches 4 (middle panel) and 1–3 (right panel) are displayed as sticks and colored in yellow. The referring amino acid is reported next to the structure and in the color of the corresponding NELF subunit (NELF-A = orange; NELF-C = blue). Lysine and arginine residues associated with the positively charged patches42 are also shown as sticks and colored in black. T157 is highlighted in pink and marked with an encircled P. Source data for (a, c, e) are provided in a Source Data file. Data shown in (b, d) are part of Supplementary Data 4, 6.
Fig 5: NELF directly binds to nascent eRNAs in vivo.a Example track showing one of the activity-induced genes, Fosb (Blue shaded at its promoter) and its nearby enhancer (Yellow shaded area) along with ChIP- (H3K27ac, NELF-E, and NELF-A), eCLIP-, GRO-, and mRNA-seq data. b, c The coverage profiles of the crosslinking sites (green line) from eCLIP-seq and NELF ChIP-seq coverage profiles (red line) present up to 600 bp downstream from the TSSs as defined by ENCODE annotation of pre-mRNAs (9028) (b) and from the de novo defined 5'-ends (TSSs) of intergenic eRNAs (1226) (c) at different time points after KCl stimulation (0 and 30 min). NELF peak (~60–70 bp downstream of the TSSs) portions (thin red box) from ChIP-seq data are also shown. The 607 overlapping eRNAs out of 1226 eRNAs were selected after transcript calling with GRO-seq (KCl 30 min). A total of 7242 annotated pre-mRNAs having one or more crosslinking sites out of 9028 pre-mRNAs (b) and a total of 240 eRNAs having crosslinking sites out of 607 eRNAs (c) were used for these analyzes. See also the figure legend of Supplementary Fig. 8a, b. d, e The coverage profiles of eCLIP-seq (green line) from the normalized number of crosslinking sites considering the expression level from GRO-seq and Exo-seq coverage profiles (purple line) for a total of 7242 annotated pre-mRNAs having crosslinking sites out of 9028 pre-mRNAs (d) and a total of 240 eRNAs having crosslinking sites out of 607 eRNAs (e) at KCl stimulation (0 and 30 min). NELF peak (~60–70 bp downstream of the TSSs) portions (thin red box) from ChIP-seq data were also shown. f–i Pie charts that show the proportion of crosslinking sites present in three distance windows (1–200, 201–400, or 401–600 nucleotides) for the total annotated (9028) (f) or KCl-up/NELF-bound (548) (h) pre-mRNAs, and the total intergenic (1226) (g) or KCl-up/NELF-bound (144) (i) eRNAs at different time points after KCl stimulation. P values were determined by Chi-squared. j ChIP-seq analysis of the NELF-E protein. The pie chart shows the genomic distribution of annotated NELF-E peaks. 5'UTR 5' untranslated region, 3'UTR 3' untranslated region, CDS coding sequence, TSS transcription start site, TTS transcription termination site. Source data for (b–j) are provided in a Source Data file.
Supplier Page from Abcam for Anti-NELFe antibody [EPR11600]